Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil up around 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Deciphera Pharmaceuticals (DCPH) Misses Q2 EPS by 6c
August 3, 2021 4:42 PM EDTDeciphera Pharmaceuticals (NASDAQ: DCPH) reported Q2 EPS of ($1.21), $0.06 worse than the analyst estimate of ($1.15). Revenue for the quarter came in at $22 million versus the consensus estimate of $22 million.
For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.
... More